Systematic review / meta-analysis / 2022
Nut intake of 28 g/day was linked to lower risks of cardiovascular disease, cancer deaths, and all-cause mortality in an umbrella review.
An umbrella review analyzed 89 articles on nut and seed consumption and health outcomes, including 23 meta-analyses on disease and mortality and 66 on biomarkers. Eating 28 g/d of nuts compared with not eating nuts was associated with a 21% relative risk reduction in cardiovascular disease, an 11% reduction in cancer deaths, and a 22% reduction in all-cause mortality. Nut intake was also inversely associated with mortality from respiratory diseases, infectious diseases, and diabetes, though associations with diabetes incidence were mixed. Allergy and adverse reactions were reported in 1-2% of adult populations with substantial heterogeneity.
Shows an association, not proof of cause and effect.
- Study type
- Umbrella review of systematic reviews and meta-analyses
- Who was studied
- Evidence extracted from 89 articles including observational and trial meta-analyses
- What was measured
- Cardiovascular disease, cancer, diabetes, obesity, respiratory disease, mortality, and disease biomarkers
THE PAPER
Consumption of Nuts and Seeds and Health Outcomes Including Cardiovascular Disease, Diabetes and Metabolic Disease, Cancer, and Mortality: An Umbrella Review.
Balakrishna R, Bjørnerud T, Bemanian M, Aune D, Fadnes LT. Adv Nutr, 2022.
PubMed 36041171 ↗DOI 10.1096/fasebj.28.1_supplement.1025.6 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.